HARMINDER SINGH SETHI MD NPI 1275563033

NPI Information

  • NPI: 1275563033
  • Provider Name: HARMINDER SINGH SETHI, MD
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 6505 BELCREST RD
    SUITE #110
    HYATTSVILLE, MD
    ZIP 20782
  • Phone: (301) 779-8800

Map and Directions

Get Directions

NPI Details

Harminder Singh Sethi, MD is a hematology and oncology internal medicine in Hyattsville, MD with 35 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Harminder Singh Sethi, MD NPI is 1275563033. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

6505 BELCREST RD
SUITE #110
HYATTSVILLE, MD
ZIP 20782-011
Phone: (301) 779-8800
Fax: (202) 636-9088

The NPI 1275563033 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, iron sucrose, 1 mg (HCPCS:J1756)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Infusion, normal saline solution, 250 cc (HCPCS:J7050)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Folic acid level, serum (HCPCS:82746)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Vitamin d-3 level (HCPCS:82306)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Measurement of substance using immunoassay technique (HCPCS:83520)
  • Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or (HCPCS:G2212)

The enumeration date for this NPI number is 7/4/2006 and was last updated on 11/30/2014.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & OncologyD52767MARYLANDYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.